P1,P4-Di(uridine-5′-tetraphosphate) CAS 211427-08-6
N-Acetylneuraminic acid CAS 131-48-6
26 8 月, 2020Talc CAS 14807-96-6
26 8 月, 2020
P1,P4-Di(uridine-5′-tetraphosphate) Typical Properties
| Product name | INS 365 |
| CAS | 211427-08-6 |
| Synonyms | Diquafosol Tetrasoudium or P1,P4-Di(Uridine-5′-Tetraphosphate);INS 365;D03864;Diquafosol sodium;Diquafosol sodium (jan);Diquafosol tetrasodium;Diquafosol tetrasodium (usan);Diquafosol Impurity 7(UP4U) |
| Molecular formula | C18H26N4O23P4·4Na |
| Molecular weight | / |
| Purity | 98% |
| Appearance | White powder |
| Brand Name | Fousi chemical |
P1,P4-Di(uridine-5′-tetraphosphate) Usage
Diquafoxol tetrasodium works by activating the P2Y2 receptor in the conjunctiva and promoting the secretion of water and mucin components in tear fluid, thereby improving the quality and quantity of tear fluid.
Diquafosol tetrasodium eye drops are the first P2Y2 receptor agonist eye drops approved for marketing in the world. They treat dry eye with a new mechanism of action: improve the symptoms of dry eye by promoting the secretion of water and mucin, and bring the tear film closer normal status. In clinical studies in Japan, no serious ocular and systemic adverse reactions were found. Diquas is well tolerated, so it can be used for long-term treatment of dry eye symptoms
P1,P4-Di(uridine-5′-tetraphosphate) Packaging and Shipping
Packaging:
1kg/bottle or bag
25kgs/drum or bag
Shipping: Shipped in 1-3 days after payment
P1,P4-Di(uridine-5′-tetraphosphate) Storage
2-8°C
P1,P4-Di(uridine-5′-tetraphosphate) Uses
Enhancement of mucosal hydration in the treatment of chronic dry eye (P2Y2 receptor antagonist).